文献速递泌尿生殖腹部MR

多参数MRI评估膀胱癌人表皮生长因子受体2表达的探索性研究

Multiparametric MR characterization for human epithelial growth factor receptor 2 expression in bladder cancer: an exploratory study.
PubMed 文献 · Abdom Radiol (NY) · 2024-06-13

该研究回顾性纳入2021年4月至2023年7月90例经病理确诊的膀胱癌患者,术前接受包含合成MRI和DWI的多参数MRI检查,获取T1、T2、质子密度和表观扩散系数值。最终76例纳入分析,HER2阳性组25例、阴性组51例,阳性组ADC、T1、T2值均显著高于阴性组(均P<0.05)。ADC值联合肿瘤分级评估HER2表达的AUC为0.864,诊断效能最佳;作者认为多参数MR特征可准确评估膀胱癌HER2表达状态,可能进一步指导个体化抗HER2靶向治疗策略的制定。

要点

  • HER2阳性膀胱癌的ADC、T1、T2值均显著高于HER2阴性者(均P<0.05)。
  • ADC值联合肿瘤分级评估HER2表达的AUC达0.864,为最佳组合。
  • 多参数MR特征可能用于评估膀胱癌HER2表达状态。

核心结论

  • 多参数MR特征可准确评估膀胱癌HER2表达状态,可能进一步指导个体化抗HER2靶向治疗策略的制定。

研究设计与样本

  • 回顾性研究,2021年4月至2023年7月收集90例经病理确诊膀胱癌患者的术前影像,最终76例纳入分析(平均年龄63.59岁±12.84[SD],男55例);所有患者接受包含合成MRI和DWI的多参数MRI检查,获得T1、T2、PD和ADC值,以病理HER2表达状态为参考。

关键影像表现/征象

  • HER2阳性组ADC值显著高于HER2阴性组(P<0.05)。
  • HER2阳性组T1值显著高于HER2阴性组(P<0.05)。
  • HER2阳性组T2值显著高于HER2阴性组(P<0.05)。

诊断标准与关键数值

  • ADC值联合肿瘤分级评估HER2表达状态的AUC为0.864,为最佳诊断效能。
  • HER2阳性组与阴性组间ADC、T1、T2值差异均有统计学意义(均P<0.05)。

临床应用与阅片要点

  • 阅片时可关注膀胱癌病灶的ADC、T1、T2值,HER2阳性者这些定量值倾向于更高。
  • 作者认为多参数MR特征可准确评估HER2表达状态,可能进一步指导个体化抗HER2靶向治疗策略的制定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the application value of multiparametric MRI in evaluating the expression status of human epithelial growth factor receptor 2 (HER2) in bladder cancer (BCa).

METHODS: From April 2021 to July 2023, preoperative imaging manifestations of 90 patients with pathologically confirmed BCa were retrospectively collected and analyzed. All patients underwent multiparametric MRI including synthetic MRI, DWI, from which the T1, T2, proton density (PD) and apparent diffusion coefficient (ADC) values were obtained. The clinical and imaging characteristics as well as quantitative parameters (T1, T2, PD and ADC values) between HER2-positive and -negative BCa were compared using student t test and chi-square test. The diagnostic efficacy of parameters in predicting HER2 expression status was evaluated by calculating the area under ROC curve (AUC).

RESULTS: In total, 76 patients (mean age, 63.59 years ± 12.84 [SD]; 55 men) were included: 51 with HER2-negative and 25 with HER2-positive BCa. HER2-positive group demonstrated significantly higher ADC, T1, and T2 values than HER2-negative group (all P < 0.05). The combination of ADC values and tumor grade yielded the best diagnostic performance in evaluating HER2 expression level with an AUC of 0.864.

CONCLUSION: The multiparametric MR characterization can accurately evaluate the HER2 expression status in BCa, which may further guide the determination of individualized anti-HER2 targeted therapy strategies.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kong L, Ling J, Cao W, et al. Multiparametric MR characterization for human epithelial growth factor receptor 2 expression in bladder cancer: an exploratory study. Abdom Radiol (NY). 2024. PMID: 38867120. doi:10.1007/s00261-024-04378-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。